Comparison Overview

Olympus Corporation of the Americas

VS

Edwards Lifesciences

Olympus Corporation of the Americas

3500 Corporate Parkway, None, Center Valley, Pennsylvania, US, 18034-0610
Last Update: 2025-12-01
Between 700 and 749

At Olympus, we are committed to Our Purpose of making people’s lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide best-in-class solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. Olympus Corporation of the Americas, a wholly owned subsidiary of Olympus Corporation, is headquartered in Center Valley, Pennsylvania, USA, and employs more than 4,500 employees throughout locations in North and South America.

NAICS: 3391
NAICS Definition: Medical Equipment and Supplies Manufacturing
Employees: 5,032
Subsidiaries: 3
12-month incidents
0
Known data breaches
1
Attack type number
3

Edwards Lifesciences

One Edwards Way, None, Irvine, CA, US, 92614
Last Update: 2025-12-01
Between 800 and 849

Edwards Lifesciences (NYSE: EW), is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. We thrive on discovery and expanding the boundaries of medical technology, serving patients in 100+ countries, with the help of our employees in areas including Clinical Affairs, Quality Engineering, Research & Development, Regulatory Affairs, Sales & Marketing, corporate functions and more.  Contact Us We want to hear from you and engage in meaningful discussions. However, please note that we are not equipped to provide customer, candidate, or technical support through this platform. If you require assistance from those teams, please find their contact information here: https://www.edwards.com/aboutus/contactus If you’re a patient in need of medical advice, please contact your healthcare provider directly. We reserve the right to remove any comments that are off-topic, repetitive, or include hate speech, profanity, or offensive language. Additionally, we will not engage in discussions about competitor products, off-label use of Edwards products, or unsubstantiated/misleading claims that could cause harm. All Terms and Conditions of LinkedIn apply. For the Edwards Lifesciences privacy policy, visit https://www.edwards.com/legal/privacypolicy.

NAICS: 3391
NAICS Definition: Medical Equipment and Supplies Manufacturing
Employees: 13,399
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/olympus.jpeg
Olympus Corporation of the Americas
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/edwards-lifesciences.jpeg
Edwards Lifesciences
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Olympus Corporation of the Americas
100%
Compliance Rate
0/4 Standards Verified
Edwards Lifesciences
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for Olympus Corporation of the Americas in 2025.

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for Edwards Lifesciences in 2025.

Incident History — Olympus Corporation of the Americas (X = Date, Y = Severity)

Olympus Corporation of the Americas cyber incidents detection timeline including parent company and subsidiaries

Incident History — Edwards Lifesciences (X = Date, Y = Severity)

Edwards Lifesciences cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/olympus.jpeg
Olympus Corporation of the Americas
Incidents

Date Detected: 10/2021
Type:Breach
Attack Vector: Unauthorized Access
Blog: Blog

Date Detected: 10/2021
Type:Cyber Attack
Blog: Blog

Date Detected: 09/2021
Type:Ransomware
Blog: Blog
https://images.rankiteo.com/companyimages/edwards-lifesciences.jpeg
Edwards Lifesciences
Incidents

No Incident

FAQ

Edwards Lifesciences company demonstrates a stronger AI Cybersecurity Score compared to Olympus Corporation of the Americas company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Olympus Corporation of the Americas company has historically faced a number of disclosed cyber incidents, whereas Edwards Lifesciences company has not reported any.

In the current year, Edwards Lifesciences company and Olympus Corporation of the Americas company have not reported any cyber incidents.

Olympus Corporation of the Americas company has confirmed experiencing a ransomware attack, while Edwards Lifesciences company has not reported such incidents publicly.

Olympus Corporation of the Americas company has disclosed at least one data breach, while the other Edwards Lifesciences company has not reported such incidents publicly.

Olympus Corporation of the Americas company has reported targeted cyberattacks, while Edwards Lifesciences company has not reported such incidents publicly.

Neither Olympus Corporation of the Americas company nor Edwards Lifesciences company has reported experiencing or disclosing vulnerabilities publicly.

Neither Olympus Corporation of the Americas nor Edwards Lifesciences holds any compliance certifications.

Neither company holds any compliance certifications.

Olympus Corporation of the Americas company has more subsidiaries worldwide compared to Edwards Lifesciences company.

Edwards Lifesciences company employs more people globally than Olympus Corporation of the Americas company, reflecting its scale as a Medical Equipment Manufacturing.

Neither Olympus Corporation of the Americas nor Edwards Lifesciences holds SOC 2 Type 1 certification.

Neither Olympus Corporation of the Americas nor Edwards Lifesciences holds SOC 2 Type 2 certification.

Neither Olympus Corporation of the Americas nor Edwards Lifesciences holds ISO 27001 certification.

Neither Olympus Corporation of the Americas nor Edwards Lifesciences holds PCI DSS certification.

Neither Olympus Corporation of the Americas nor Edwards Lifesciences holds HIPAA certification.

Neither Olympus Corporation of the Americas nor Edwards Lifesciences holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Sigstore Timestamp Authority is a service for issuing RFC 3161 timestamps. Prior to 2.0.3, Function api.ParseJSONRequest currently splits (via a call to strings.Split) an optionally-provided OID (which is untrusted data) on periods. Similarly, function api.getContentType splits the Content-Type header (which is also untrusted data) on an application string. As a result, in the face of a malicious request with either an excessively long OID in the payload containing many period characters or a malformed Content-Type header, a call to api.ParseJSONRequest or api.getContentType incurs allocations of O(n) bytes (where n stands for the length of the function's argument). This vulnerability is fixed in 2.0.3.

Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Description

Monkeytype is a minimalistic and customizable typing test. In 25.49.0 and earlier, there is improper handling of user input which allows an attacker to execute malicious javascript on anyone viewing a malicious quote submission. quote.text and quote.source are user input, and they're inserted straight into the DOM. If they contain HTML tags, they will be rendered (after some escaping using quotes and textarea tags).

Risk Information
cvss4
Base: 7.1
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

SysReptor is a fully customizable pentest reporting platform. Prior to 2025.102, there is a Stored Cross-Site Scripting (XSS) vulnerability allows authenticated users to execute malicious JavaScript in the context of other logged-in users by uploading malicious JavaScript files in the web UI. This vulnerability is fixed in 2025.102.

Risk Information
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N
Description

Taiko Alethia is an Ethereum-equivalent, permissionless, based rollup designed to scale Ethereum without compromising its fundamental properties. In 2.3.1 and earlier, TaikoInbox._verifyBatches (packages/protocol/contracts/layer1/based/TaikoInbox.sol:627-678) advanced the local tid to whatever transition matched the current blockHash before knowing whether that batch would actually be verified. When the loop later broke (e.g., cooldown window not yet passed or transition invalidated), the function still wrote that newer tid into batches[lastVerifiedBatchId].verifiedTransitionId after decrementing batchId. Result: the last verified batch could end up pointing at a transition index from the next batch (often zeroed), corrupting the verified chain pointer.

Risk Information
cvss4
Base: 8.0
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:U/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A flaw has been found in youlaitech youlai-mall 1.0.0/2.0.0. Affected is the function getById/updateAddress/deleteAddress of the file /mall-ums/app-api/v1/addresses/. Executing manipulation can lead to improper control of dynamically-identified variables. The attack can be executed remotely. The exploit has been published and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 6.5
Severity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
cvss3
Base: 6.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X